OrbiMed Capital GP III LLC, 10% Owner at Roka BioScience, Inc. (ROKA), sold 567,922 shares at $0.72 ($413K) on 2017-09-28, disclosed to the SEC on 2017-10-02.
Open-market sale of $413k ROKA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.72 | 3,592 | $3K | 0.6% |
| 2 | $0.72 | 376,950 | $271K | 65.8% |
| 3 | $0.74 | 888 | $657 | 0.2% |
| 4 | $0.74 | 93,246 | $69K | 16.7% |
| 5 | $0.74 | 93,246 | $69K | 16.7% |
| Total | $0.73 avg | 567,922 |
| $413K |
| 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |